jcp conference-coverage

Conference Coverage

Adding Veliparib to Chemo Does Not Significantly Improve Health-Related QoL in Advanced Ovarian Cancer

09/24/2020

Journal of Clinical Pathways

Conference Coverage

Determinants Impacting Provider Decisions to Prescribe Low-Value Prostate Cancer Treatment

09/18/2020

Journal of Clinical Pathways

Conference Coverage

Clinical and Economic Burden of MCL in the VHA Population

09/14/2020

Journal of Clinical Pathways

Conference Coverage

Feasibility of In-Class Transition to Oral Ixazomib-Lenalidomide-Dexamethasone in Community-Based MM Population

09/14/2020

Journal of Clinical Pathways

Conference Coverage

Significant Clinical and Economic Burden Associated With WM in VHA Population

09/11/2020

Significant clinical and economic burden remain among patients with WM in the US Veterans Health Administration population, according to a recent study presented at the Association of VA Hematology/Oncology Annual Meeting.

Significant clinical and...

09/11/2020

Journal of Clinical Pathways

Conference Coverage

ASCO Annual Meeting 2020

05/27/2020

The ASCO 2020 Virtual Scientific Program (May 29-31) provided the opportunity to connect with oncology professionals around the world to explore and discuss cutting-edge research, therapies, and state-of-the-art...

The...

05/27/2020

Journal of Clinical Pathways

Conference Coverage

2020 Community Oncology Alliance Annual Conference

05/19/2020

JCP Editors

The 2020 Community Oncology Alliance (COA) Annual Conference had an educational agenda planned to benefit the nationwide workforce of community oncology professionals and allied industries. It was delivered through a...

The...

05/19/2020

Journal of Clinical Pathways

Conference Coverage

The 2019 American Society of Hematology Annual Meeting & Exposition

12/17/2019

JCP Editors

The American Society of Hematology (ASH) is the world’s largest professional society serving both clinicians and scientists working in the hematology field with over 17,000 members from almost 100...

The...

12/17/2019

Journal of Clinical Pathways

Conference Coverage

Clinical Pathways for Ovarian Cancer

11/15/2019

JCP Editors

For ovarian cancer, in which treatment recurrence is a challenge and long-term maintenance therapy is often required, the clinical and financial implications of long-term treatment may differ from those of other...

For...

11/15/2019

Journal of Clinical Pathways

Conference Coverage

Highlighted Presentations from the 2018 Clinical Pathways Congress

11/15/2019

JCP Editors

Pros and Cons of Vendor- and Provider-Developed Pathways On Day 1 of the 2018 Clinical Pathways Congress, Bobby Daly, MD, MBA, Memorial Sloan Kettering Cancer Center (New York, NY), and Robin T. Zon, MD, FACP,...

Pros...

11/15/2019

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Conference Coverage

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products